Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT06788171	TitlePULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM	Fase Fase 2	Date Added 2025-03-25	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT03650348	TitlePRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors	Fase Fase 1	Date Added 2018-08-28	Ubicación California, United States Louisiana, United States New York, United States Ohio, United States Texas, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas PRS-343 in Combination with Atezolizumab, Tecentriq	Etiquetas MSS/ MMRp
NCT ID NCT01697371	TitleLa terapia de protones en el tratamiento de las metástasis hepáticas	Fase No aplicable	Date Added 2012-10-02	Ubicación California, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06120127	TitlePostoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Fase Fase 2	Date Added 2023-11-07	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Chemotherapy, PD-1 antibody	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04117087	TitlePooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer	Fase Fase 1	Date Added 2019-10-07	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT06300463	TitlePlataforma de estudio de combinaciones de inmunoterapia en metástasis hepáticas de cáncer colorrectal	Fase Fase 2	Date Added 2024-03-08	Ubicación New York, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas AGEN1423, Balstilimab, Botensilimab	Etiquetas MSS/ MMRp
NCT ID NCT03868228	TitlePIPAC para el tratamiento de las metástasis colorrectales peritoneales	Fase Fase 1	Date Added 2019-03-11	Ubicación Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04708470	TitlePhase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer	Fase Phase 1, Phase 2	Date Added 2021-01-14	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Bintrafusp alfa, Entinostat, NHS-IL12	Etiquetas MSS/ MMRp
NCT ID NCT06149481	TitleEstudio de fase I/II del régimen de inmunoterapia combinada: SX-682, Vacuna TriAdeno, Retifanlimab y Agonista de IL-15 N-803 (STAR15) para el Cáncer Colorrectal Metastásico (CCRm).	Fase Phase 1, Phase 2	Date Added 2023-11-29	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas N-803, Retifanlimab, SX-682	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02484404	TitleEstudio de Fase I/II del Anticuerpo Anti-Ligando de Muerte Programada-1 Durvalumab (MEDI4736) en Combinación con Olaparib y/o Cediranib para Tumores Sólidos Avanzados y Cáncer de Ovario, Mama Triple Negativa, Pulmón, Próstata y Colorrectal Avanzado o Recurrente....	Fase Phase 1, Phase 2	Date Added 2015-06-29	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Cediranib, durvalumab, Olaparib	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 81 to 90 of 299 entries